Ceramides may play a role in differentiating bipolar disorder and major depressive disorders. Metabolomic profiling may improve the differential diagnosis of mood disorders, according to a proof-of-concept study published online Oct. 25 in JAMA Psychiatry. Jakub Tomasik, Ph.D., from the University of Cambridge in the United Kingdom, and colleagues examined metabolomic biomarker signatures from dried blood...